CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights

Group 1: Company Performance - CVS Health closed at $51.96, reflecting a -0.35% change from the previous day, underperforming the S&P 500's daily loss of 0.21% [1] - Over the past month, CVS Health shares have appreciated by 15.15%, outperforming the Retail-Wholesale sector's loss of 2.84% and the S&P 500's loss of 1.56% [1] Group 2: Upcoming Financial Results - CVS Health is set to announce its earnings on February 12, 2025, with an anticipated EPS of$ 0.94, representing a 55.66% decline compared to the same quarter last year [2] - The consensus estimate forecasts revenue of $97.27 billion, indicating a 3.69% growth compared to the corresponding quarter of the prior year [2] Group 3: Analyst Forecasts and Rankings - Recent revisions to analyst forecasts for CVS Health are important as they reflect short-term business trends, with positive changes indicating a favorable outlook on the company's health and profitability [3] - The Zacks Rank system, which assesses estimated changes, currently ranks CVS Health as 5 (Strong Sell), with the Zacks Consensus EPS estimate moving 2.08% lower in the past month [5] Group 4: Valuation Metrics - CVS Health has a Forward P/E ratio of 8.56, which is a premium compared to its industry's Forward P/E of 7.89 [6] - The company also has a PEG ratio of 0.78, aligning with the average PEG ratio of the Retail - Pharmacies and Drug Stores industry [7] Group 5: Industry Context - The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector, holding a Zacks Industry Rank of 235, placing it in the bottom 7% of over 250 industries [8]